Harald Mosler

Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY.

GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium.

Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Part of Servier SAS, Servier Deutschland GmbH is a German company that focuses on meeting the needs of patients and innovation. The company is based in Munich, Germany. The CEOs are Franck Parisot and Oliver Kirst. The company was founded in 1996.

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.

The European Vaccine Initiative manufactures vaccines. The private company is based in London, UK.

Park project AGFA GmbH & Co.KG provides investment services. The private company is based in Grünwald, Germany. The CEO of the German company is Ralf Büschl.

develops vaccines to cure disorders of the immune system. Its services include preclinical evaluation, clinical immunomonitoring, technical transfer, consulting and training services, cell, gene, and protein readout development, and clinical biomarker panels validation. The company was founded in 2007 and is headquartered in Gosselies, Belgium.

Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium.

20Med Therapeutics BV operates as a biomedical company. It focuses on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery. The company was founded by Johan F. J. Engbersen in 2011 and is headquartered in Enschede, the Netherlands.

4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011.

MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Omnicare Holding GmbH & Co. KG engages in the development, manufacture, and supply of oncological products. The company was founded on 2012 and is headquartered in Unterföhring, Germany.

InfanDx AG develops diagnostics tests for the care of neonates. The firm develops a new generation of diagnostic tests for the care of neonates. The company is headquartered in Cologne, Germany.

Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.

PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.

Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium.

Arnika Beteiligungen GmbH provides management services. The private company is based in Poing, Germany. The German company was founded in 2005. The CEO is Wolfgang Schwandner.

Park Immobilien Projektentwicklung und Planung GmbH provides architect services. The private company is based in Munich, Germany. The CEOs of the German company are Gerald Purucker, Adenauer Patrick, Ralf Büschl.

R1 Erste Beteiligungsgesellschaft mbH provides investment services. The private company is based in Gruenwald, Germany. The CEOs are Marlena Büschl, Ralf Büschl, Martin Enax, Gesine Büschl. The German company was founded in 2010.

Leopoldstraße 204 GmbH & Co. KG is a private company based in Gruenwald, Germany. The CEOs of the German company are Klaus Wallner, Ralf Büschl. The company engages in buying and selling lands, buildings & flats.

Büschl Unternehmensgruppe Holding GmbH & Co. KG is a German company that specializes in architecture, project development, and real estate construction. The private company is based in Gruenwald, Germany. The company's website provides information about its completed and ongoing projects, including residential and commercial buildings, as well as its commitment to sustainability and social responsibility. The company has been recognized as the leading project developer in the Munich metropolitan region for five consecutive years. The company was founded in 1963 by Günter Büschl, and the CEO is Ralf Büschl.

Part of Eckpfeiler Immobilien Gruppe GmbH, ALLPG Immobiliengesellschaft mbH & Co. KG engages in management of land, buildings and apartments. The company is based in Pullach, Germany. The CEOs of the German company are Wolfgang Bogner, Ralf Büschl.

Eggarten Projektentwicklung GmbH & Co. KG buys and sells land, buildings, and apartments. The joint venture company is based in Gruenwald, Germany. The CEOs are Stefan Ondracek, Norbert Stangelmayer, Ralf Büschl. The German company was founded in 2016.

Park Immobilien Beteiligungsgesellschaft mbH provides real estate services. The private company is based in Gruenwald, Germany. The CEOs of the German company are Dirk Otto, Ralf Büschl.

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.

August Faller GmbH & Co. KG engages in the manufacture and supply of secondary packaging to the pharmaceutical, medical devices, and chemistry industry. It offers folding cartons, leaflets, labels, and combination products. The company was founded by August Faller in 1882 and is headquartered in Waldkirch, Germany.

DNAlytics SA engages in the development of data-driven precision medicine solutions. The firm provides consultancy services; and academic medical, biological, and clinical research laboratories for the pharmaceutical, biotechnology and In-Vitro Diagnostic companies. It also offers software programs unde rthe REED, LiblineaR, jForest, and BLISS brands. The company was founded by Pierre Dupont and Thibault Helleputte in 2012 and is headquartered in Louvain-la-Neuve, Belgium.